Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
1.260
0.00 (0.00%)
At close: Nov 20, 2024, 4:00 PM
1.400
+0.140 (11.10%)
After-hours: Nov 20, 2024, 7:57 PM EST
Theriva Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 7 | 7 | 36 | 8 | 9 | |
| Market Cap Growth | -65.88% | 6.57% | -80.86% | 369.37% | -10.11% | 12.82% | |
| Enterprise Value | -12 | -19 | -39 | -37 | 15 | 5 | |
| Last Close Price | 1.26 | 10.75 | 11.37 | 68.05 | 95.75 | 126.72 | |
| PB Ratio | 0.13 | 0.18 | 0.13 | 0.55 | 1.46 | 0.74 | |
| P/TBV Ratio | 0.13 | 0.23 | 0.15 | 0.55 | - | - | |
| Debt / Equity Ratio | 0.07 | 0.05 | 0.03 | 0.02 | 0.09 | 0.06 | |
| Quick Ratio | 2.49 | 3.73 | 5.95 | 18.94 | 2.26 | 2.85 | |
| Current Ratio | 2.67 | 4.07 | 6.45 | 19.37 | 2.67 | 3.11 | |
| Return on Equity (ROE) | -77.91% | -38.93% | -32.82% | -40.38% | -120.82% | -81.07% | |
| Return on Assets (ROA) | -29.54% | -21.73% | -16.95% | -22.65% | -49.52% | -41.33% | |
| Return on Capital (ROIC) | -41.42% | -28.15% | -19.57% | -24.55% | -70.79% | -50.64% | |
| Earnings Yield | -932.18% | -250.32% | -286.18% | -39.69% | -131.15% | -179.63% | |
| FCF Yield | -261.91% | -279.10% | -35.90% | -159.02% | -162.85% | |
| Buyback Yield / Dilution | -30.03% | -5.09% | -25.76% | -541.07% | -15.65% | -163.75% | |
| Total Shareholder Return | -30.03% | -5.09% | -25.76% | -541.07% | -15.65% | -163.75% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.